Hurdles In Logistics And Distribution Increase With The Growth Of Gene And Cell Therapies

The Food and Drug Administration (FDA) and related industries estimate 40 new cell and gene therapies to be available by 2024 in addition to the 800 already being processed. While beneficial to patients and further research, these advancements have introduced new challenges in logistics and distribution including delivery methods, scalability, marketing factors, and stakeholder partnerships...